Janice N. Li

610 University Ave
Toronto, ON M5G2C4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer.

Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer.

Journal: International journal of molecular sciences

Published: March 25, 2026

Identifying Patients With High-Risk Stage I NSCLC Using a Tumor-Informed Plasma ctDNA Assay.

Identifying Patients With High-Risk Stage I NSCLC Using a Tumor-Informed Plasma ctDNA Assay.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: January 27, 2026

Are ultrasensitive ctDNA assays ready for clinical use in early-stage NSCLC?

Are ultrasensitive ctDNA assays ready for clinical use in early-stage NSCLC?

Journal: Cell

Published: November 12, 2025

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.

Journal: JTO clinical and research reports

Published: August 15, 2025

Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1.

Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 21, 2025

Assessing the feasibility and external validity of natural language processing-extracted data for advanced lung cancer patients.

Assessing the feasibility and external validity of natural language processing-extracted data for advanced lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 14, 2024

Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications.

Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications.

Journal: Genes

Published: August 11, 2024

Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC.

Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC.

Journal: JTO clinical and research reports

Published: February 06, 2024

Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer.

Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: July 20, 2022

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.

Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.

Journal: iScience

Published: July 13, 2022

PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC.

PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 09, 2022

iRECIST and atypical patterns of response to immuno-oncology drugs.

iRECIST and atypical patterns of response to immuno-oncology drugs.

Journal: Journal for immunotherapy of cancer

Published: June 02, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026